Status:
COMPLETED
Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Morbid Obesity
High BMI
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The QL 2 block is a novel fascial plane block recently described by Blanco and colleagues in which local anesthetic is deposited adjacent to the antero-lateral aspect of the quadratus lumborum muscle....
Detailed Description
The QL 2 block is a novel fascial plane block recently described by Blanco and colleagues in which local anesthetic is deposited adjacent to the antero-lateral aspect of the quadratus lumborum muscle....
Eligibility Criteria
Inclusion
- Patients scheduled to undergo laparoscopic gastric sleeve gastrectomy
- 18-65 years of age
- BMI\> 35 kg/m2.
Exclusion
- Contraindications to administration of local anesthesia (e.g. local anesthetic allergy)
- Contraindication/allergy to acetaminophen or ketorolac
- History of substance abuse or chronic opioid use
- Coagulopathy
- Patients receiving systemic anticoagulation
- Local infection
- ASA 4
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2021
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04073056
Start Date
August 1 2018
End Date
February 23 2021
Last Update
January 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai St. Lukes Hospital
New York, New York, United States, 10025